73 related articles for article (PubMed ID: 19900774)
1. Inner ear pathology of alpha-galactosidase A deficient mice, a model of Fabry disease.
Sakurai Y; Suzuki R; Yoshida R; Kojima H; Watanabe M; Manome Y; Ohashi T; Eto Y; Moriyama H
Auris Nasus Larynx; 2010 Jun; 37(3):274-80. PubMed ID: 19900774
[TBL] [Abstract][Full Text] [Related]
2. Normal hearing in alpha-galactosidase A-deficient mice, the mouse model for Fabry disease.
Noben-Trauth K; Neely H; Brady RO
Hear Res; 2007 Dec; 234(1-2):10-4. PubMed ID: 17933476
[TBL] [Abstract][Full Text] [Related]
3. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency].
Guo YK; Xie DH; Yang XM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682
[TBL] [Abstract][Full Text] [Related]
4. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS
J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680
[TBL] [Abstract][Full Text] [Related]
5. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
6. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
7. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
[TBL] [Abstract][Full Text] [Related]
8. Cu/Zn SOD deficiency potentiates hearing loss and cochlear pathology in aged 129,CD-1 mice.
McFadden SL; Ding D; Burkard RF; Jiang H; Reaume AG; Flood DG; Salvi RJ
J Comp Neurol; 1999 Oct; 413(1):101-12. PubMed ID: 10464373
[TBL] [Abstract][Full Text] [Related]
9. α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease.
Bangari DS; Ashe KM; Desnick RJ; Maloney C; Lydon J; Piepenhagen P; Budman E; Leonard JP; Cheng SH; Marshall J; Thurberg BL
Am J Pathol; 2015 Mar; 185(3):651-65. PubMed ID: 25553976
[TBL] [Abstract][Full Text] [Related]
10. Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease.
Yokoi T; Kobayashi H; Shimada Y; Eto Y; Ishige N; Kitagawa T; Otsu M; Nakauchi H; Ida H; Ohashi T
J Gene Med; 2011 May; 13(5):262-8. PubMed ID: 21520359
[TBL] [Abstract][Full Text] [Related]
11. Apical-to-basal gradients in age-related cochlear degeneration and their relationship to "primary" loss of cochlear neurons.
Ohlemiller KK; Gagnon PM
J Comp Neurol; 2004 Nov; 479(1):103-16. PubMed ID: 15389608
[TBL] [Abstract][Full Text] [Related]
12. Blockade of interleukin-6 signaling suppressed cochlear inflammatory response and improved hearing impairment in noise-damaged mice cochlea.
Wakabayashi K; Fujioka M; Kanzaki S; Okano HJ; Shibata S; Yamashita D; Masuda M; Mihara M; Ohsugi Y; Ogawa K; Okano H
Neurosci Res; 2010 Apr; 66(4):345-52. PubMed ID: 20026135
[TBL] [Abstract][Full Text] [Related]
13. Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice.
Morishita H; Makishima T; Kaneko C; Lee YS; Segil N; Takahashi K; Kuraoka A; Nakagawa T; Nabekura J; Nakayama K; Nakayama KI
Biochem Biophys Res Commun; 2001 Jun; 284(1):142-9. PubMed ID: 11374883
[TBL] [Abstract][Full Text] [Related]
14. Detection and differentiation of sensorineural hearing loss in mice using auditory steady-state responses and transient auditory brainstem responses.
Pauli-Magnus D; Hoch G; Strenzke N; Anderson S; Jentsch TJ; Moser T
Neuroscience; 2007 Nov; 149(3):673-84. PubMed ID: 17869440
[TBL] [Abstract][Full Text] [Related]
15. Auditory development in progressive motor neuronopathy mouse mutants.
Volkenstein S; Brors D; Hansen S; Berend A; Mlynski R; Aletsee C; Dazert S
Neurosci Lett; 2009 Nov; 465(1):45-9. PubMed ID: 19735697
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
17. Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig.
Horner KC; Cazals Y; Guieu R; Lenoir M; Sauze N
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1224-32. PubMed ID: 17711987
[TBL] [Abstract][Full Text] [Related]
18. Cochlear changes in chronic otitis media.
Cureoglu S; Schachern PA; Paparella MM; Lindgren BR
Laryngoscope; 2004 Apr; 114(4):622-6. PubMed ID: 15064614
[TBL] [Abstract][Full Text] [Related]
19. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.
Klein M; Schmidt C; Kastenbauer S; Paul R; Kirschning CJ; Wagner H; Popp B; Pfister HW; Koedel U
J Infect Dis; 2007 Apr; 195(8):1189-93. PubMed ID: 17357057
[TBL] [Abstract][Full Text] [Related]
20. Progressive hearing loss in mice carrying a mutation in the p75 gene.
Sato T; Doi K; Taniguchi M; Yamashita T; Kubo T; Tohyama M
Brain Res; 2006 May; 1091(1):224-34. PubMed ID: 16564506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
